how does everyone feel?, page-5

This is a marketing and distribution game now unless FREE wish to go down trial pathway again with different trial design?

So key is distributors , markets , sales volume and margin. Then it is a simple numbers game and hoping small shareholder don't get diluted and management costs don't get stupid. There is a balance If $ raised and it leads directly to expansion of sale s and territory great especially if it speeds delivery to markets a sit will still be a seasonal product. Slower organic growth or targeted marketing advertising spend and

FRE have various ways in which they may choose to report to shareholders actual growth in markets and hopefully shareholders will understand introduction into a market is expensive up front and either FRE pays , or their distributor pays so initially margins may not look as good as they will be alter depending on marketing spend. I hope FRE reports clearly and notes any shared " shelff space" "promotion" "marketing " "rebates" volume discounts or initial order compensation so shareholders ultimately can work out average margins going forward and confidently estimate based on volumes sold approx drop to bottom line. I dislike companies who allow these to be claimed back quarterly or later and large claimbacks don't align with new large reorders etc. If not FRE will be hard to value and market price will swing about. Industry ( local distributors) generally has access to volume numbers of products in most markets , amount of illness in region so only people left out are retail shareholders in knowing.